Marker Therapeutics

$1.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.94%) Today

+$0.01 (+0.61%) As of 12:59 AM UTC after-hours

Why Robinhood?

You can buy or sell MRKR and other stocks, options, and ETFs commission-free!

About MRKR

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. The listed name for MRKR is Marker Therapeutics, Inc. Common Stock.

CEO

Peter L. Hoang

Employees

Headquarters

Houston, Texas

Founded

1991

Market Cap

79.24M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

221.85K

High Today

$1.72

Low Today

$1.64

Open Price

$1.71

Volume

136.72K

52 Week High

$3.45

52 Week Low

$1.32

Collections

MRKR Earnings

-$0.16

-$0.11

-$0.05

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours